Laminar Pharma

Palma De Mallorca, Spain

Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.

$9.3M raised

Oct 2023

Venture - Series Unknown

Biotechnology Life Science Pharmaceutical

Top Investors

Capital CellOK VentureDentol Capital

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Laminar Pharma

How much funding has Laminar Pharma raised?

Laminar Pharma has raised $9.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.

Who are Laminar Pharma's investors?

Laminar Pharma's investors include Capital Cell, OK Venture, Dentol Capital.

Where is Laminar Pharma headquartered?

Laminar Pharma is headquartered in Palma De Mallorca, Spain.

What does Laminar Pharma do?

Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.

What stage is Laminar Pharma at?

Laminar Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 5, 2023.

MLA

"Laminar Pharma — Funding & Investors." VCBacked, October 5, 2023, https://www.vcbacked.co/company/laminar-pharma. Accessed June 4, 2026.

APA

VCBacked. (2023). Laminar Pharma — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/laminar-pharma

Wikipedia (cite web)

{{cite web |title=Laminar Pharma — Funding & Investors |url=https://www.vcbacked.co/company/laminar-pharma |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 5, 2023.

Similar Companies in Biotechnology